No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Researchers developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic ...

Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...

Bahrain has achieved a medical milestone by successfully treating a patient with sickle cell disease (SCD) using ...

“CRISPR gene editing is a transformative technology for addressing genetic diseases, but delivery constraints have largely limited its therapeutic applications to liver-targeted and ex vivo [outside ...

While there currently isn’t a cure for cancer ... examples of immune checkpoint inhibitors include: Gene therapy is a way of treating diseases by editing or altering the genes within the ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Accumulation of clots causes some of the most severe symptoms of sickle cell disease, including strokes, kidney failure, ...

A strange thing happened weeks before the Food and Drug Administration approved the first treatment made with CRISPR gene editing, an all-but cure for certain patients with sickle cell disease.